Recommended by ACS and ESC guidelines (Class 1A)1,2.
Explore the clinical data and consensus reports shaping IVUS imaging in PCI and how they translate into better decisions and improved patient outcomes in clinical practice.
Why IVUS makes a difference
IVUS doesn’t just add information; it changes treatment strategy, optimises decision-making and improves patients outcomes.
Across the PCI workflow, IVUS consistently improves decision-making and outcomes.
For a deeper understanding of the clinical evidence, explore the full report below.
Explore the full IVUS clinical evidence
Access the full body of clinical and economic evidence supporting IVUS in PCI.
What is holding IVI adoption back in practice?
Despite strong clinical evidence, Intravascular Imaging (IVI), including IVUS, is still not used consistently in daily PCI practice.
Professor Javier Escaned and his colleagues highlight the practical barriers that can slow adoption and how to overcome them.
Hear Professor Javier Escaned’s perspective on overcoming the barriers to IVI adoption.
Get the key arguments to support intravascular imaging adoption in your Cath Lab.
New technologies are helping address the adoption challenges, bringing greater consistency and confidence to IVUS interpretation.
Bringing consistency to IVUS interpretation with ALA™
Automated Lesion Assessment™, or ALA™, supports IVUS interpretation by improving consistency, reducing variability, and helping clinicians make faster, more confident decisions. It is a key feature of the AVVIGO™ + system.
Hear Dr. Simon Walsh explain how ALA™ improves IVUS interpretation, the clinical data behind it, and how he implements it in daily practice.
From improving accuracy to streamlining workflow, Dr. Walsh shares how ALA™ supports both new and experienced IVUS users. Together with upcoming automated stent assessment, this creates a more consistent, end-to-end IVUS workflow, from interpretation to post-PCI validation that instils confidence in the entire team.
Take the next step with IVUS
Build your IVUS expertise and explore the solutions supporting Modern PCI practice.
Contact and support
References
1. Vrints C. et al, 2024 ESC Guidelines for the management of chronic coronary syndromes. European Heart Journal (2024) 00, 1–123 https://doi.org/10.1093/ eurheartj/ehae177.
2. Rao S.V., et al. 2025 ACC/AHA/ACEP/NAEMSP/SCAI guideline for the management of patients with acute coronary syndromes: a report of the American College of Cardiology/American Heart Association Joint Committee on Clinical Practice Guidelines. J Am Coll Cardiol. 2025;85:22: 2135-2237.
3. Fujimura T, et al. Stent Expansion Indexes to Predict Clinical Outcomes: An IVUS Substudy From ADAPT-DES. JACC Cardiovasc Interv. 2021;14(15): 1639-50.
4. Banning A, et al. Five-year outcomes after state-of-the-art percutaneous coronary revascularization in patients with de novo three-vessel disease: final results of the SYNTAX II study. Eur Heart J. 2022;43(13): 1307–16.
5. Gao XF, et al. 3-Year Outcomes of the ULTIMATE Trial Comparing Intravascular Ultrasound Versus Angiography-Guided Drug-Eluting Stent Implantation. JACC Cardiovasc Interv. 2021;14(3): 247-57.
6. Li X, et al. Intravascular ultrasound-guided versus angiography-guided percutaneous coronary intervention in acute coronary syndromes (IVUS-ACS): a two-stage, multicentre, randomised trial. Lancet. 2024; 403(10439): 1855-65.
7. Hong D, et al. Cost-Effectiveness of Intravascular Imaging-Guided Complex PCI: Prespecified Analysis of RENOVATE-COMPLEX-PCI Trial. Circ:Cardiovasc Quality and Outcomes. 2024;17(3): https://doi.org/10.1161/CIRCOUTCOMES.123.010230.
8. Escaned J, Lombardi M, Götberg M, et al. Factors contributing to low utilization of intracoronary imaging in clinical practice: A white paper. J Soc Cardiovasc Angiogr Interv. 2025;4:103607.
CAUTION:
The law restricts these devices to sale by or on the order of a physician. Indications, contraindications, warnings, and instructions for use can be found in the product labelling supplied with each device or at www.IFU-BSCI.com.
Products shown for INFORMATION purposes only and may not be approved or for sale in certain countries.
This material not intended for use in France.